Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Gene therapy with the Math1 gene helped regenerate balance-related cells and improve balance in mice.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Compression therapy improved ankle movement, reduced leg swelling, and lessened pain in patients with venous leg ulcers.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Light therapy may improve eye conditions by stimulating cell activity and increasing oxygen availability.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.